These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 29635629

  • 21. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study.
    Kung CH, Ku WW, Lee CH, Fung CP, Kuo SC, Chen TL, Lee YT.
    J Microbiol Immunol Infect; 2015 Apr; 48(2):168-74. PubMed ID: 24064292
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The prevalence of antibiotic resistance of Enterobacteriaceae strains isolated in community- and hospital-acquired infections in teaching hospitals of Hamadan, west of Iran.
    Hashemi SH, Esna-Ashari F, Tavakoli S, Mamani M.
    J Res Health Sci; 2013 May 29; 13(1):75-80. PubMed ID: 23772019
    [Abstract] [Full Text] [Related]

  • 24. Comparative in vitro activity of temocillin and other antimicrobial agents against Enterobacteriaceae isolated from patients admitted to five Belgian hospitals.
    Vanhoof R, Bérin C, Carpentier M, Fagnart O, Glupczynski Y, Mans I, Nyssen HJ, Surmont I, Van Nimmen L.
    Acta Clin Belg; 2001 May 29; 56(6):354-9. PubMed ID: 11881320
    [Abstract] [Full Text] [Related]

  • 25. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010.
    Maraki S, Mantadakis E, Michailidis L, Samonis G.
    J Microbiol Immunol Infect; 2013 Jun 29; 46(3):202-9. PubMed ID: 22795650
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae.
    Balakrishnan I, Awad-El-Kariem FM, Aali A, Kumari P, Mulla R, Tan B, Brudney D, Ladenheim D, Ghazy A, Khan I, Virgincar N, Iyer S, Carryn S, Van de Velde S.
    J Antimicrob Chemother; 2011 Nov 29; 66(11):2628-31. PubMed ID: 21810837
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.
    Afridi FI, Farooqi BJ.
    J Coll Physicians Surg Pak; 2012 Jun 29; 22(6):358-62. PubMed ID: 22630093
    [Abstract] [Full Text] [Related]

  • 30. Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia.
    Zeynudin A, Pritsch M, Schubert S, Messerer M, Liegl G, Hoelscher M, Belachew T, Wieser A.
    BMC Infect Dis; 2018 Oct 20; 18(1):524. PubMed ID: 30342476
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S, Bloemberg GV, Giger J, Meyer V, Hombach M.
    J Antimicrob Chemother; 2012 Jan 20; 67(1):159-66. PubMed ID: 21972269
    [Abstract] [Full Text] [Related]

  • 33. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].
    Baquero F, Cercenado E, Cisterna R, de la Rosa M, García-Rodríguez JA, Gobernado M, Pérez JL, Manchado P, Martín R, Pascual A, Picazo J, Prats G, Rubio C, Snyder TA, Sanz-Rodríguez C.
    Rev Esp Quimioter; 2006 Mar 20; 19(1):51-9. PubMed ID: 16688292
    [Abstract] [Full Text] [Related]

  • 34. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).
    Pfaller MA, Bassetti M, Duncan LR, Castanheira M.
    J Antimicrob Chemother; 2017 May 01; 72(5):1386-1395. PubMed ID: 28165526
    [Abstract] [Full Text] [Related]

  • 35. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to cefotaxime, ceftazidime, cefepime and aztreonam.
    Cheng NC, Liu CY, Huang YT, Liao CH, Teng LJ, Hsueh PR.
    J Antimicrob Chemother; 2012 Jun 01; 67(6):1413-21. PubMed ID: 22345386
    [Abstract] [Full Text] [Related]

  • 36. Decreased antibiotic susceptibility of Enterobacteriaceae causing community-acquired urinary tract infections in French Amazonia.
    Baizet C, Ouar-Epelboin S, Walter G, Mosnier E, Moreau B, Djossou F, Epelboin L.
    Med Mal Infect; 2019 Feb 01; 49(1):63-68. PubMed ID: 30385068
    [Abstract] [Full Text] [Related]

  • 37. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S, Gençer S, Batırel A, Hacıseyitoğlu D, Ozer S.
    Mikrobiyol Bul; 2014 Oct 01; 48(4):545-55. PubMed ID: 25492650
    [Abstract] [Full Text] [Related]

  • 38. Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae.
    Steward CD, Stocker SA, Swenson JM, O'Hara CM, Edwards JR, Gaynes RP, McGowan JE, Tenover FC.
    J Clin Microbiol; 1999 Mar 01; 37(3):544-7. PubMed ID: 9986809
    [Abstract] [Full Text] [Related]

  • 39. Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital.
    Gibold L, Robin F, Tan RN, Delmas J, Bonnet R.
    Clin Microbiol Infect; 2014 Jan 01; 20(1):O20-6. PubMed ID: 23927626
    [Abstract] [Full Text] [Related]

  • 40. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
    Zykov IN, Sundsfjord A, Småbrekke L, Samuelsen Ø.
    Infect Dis (Lond); 2016 Feb 01; 48(2):99-107. PubMed ID: 26414659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.